world

Cholesterol drug setback casts doubt over multibillion-dollar race

CNBC

September 8, 2026

via CNBC

You're reading one story from Newsaly

Newsaly brings together 60,000+ newspaper articles, 30,000+ podcasts and 10,000+ magazine articles from around the world.

A World Of News, One Window.

Novartis’ failure raises the stakes for Amgen and Eli Lilly in the race to turn lower Lp(a) levels into fewer heart attacks and strokes.

Read the full story

Explore newspapers from around the world.

Discover podcasts and listen to the latest conversations and news.

Explore magazine articles from around the world.

Share a 15-second voice reaction. Voices automatically disappear after 10 days.

Be the first to share a voice on this article.